These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30462889)

  • 1. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
    Koga T; Sato T; Furukawa K; Morimoto S; Endo Y; Umeda M; Sumiyoshi R; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Nakamura H; Kawakami A
    Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice.
    Koga T; Mizui M; Yoshida N; Otomo K; Lieberman LA; Crispín JC; Tsokos GC
    Autoimmunity; 2014 Nov; 47(7):445-50. PubMed ID: 24829059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4.
    Shui B; Xia W; Wen C; Ding X
    J Nat Med; 2015 Jul; 69(3):349-57. PubMed ID: 25821132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV.
    Ichinose K; Juang YT; Crispín JC; Kis-Toth K; Tsokos GC
    Arthritis Rheum; 2011 Feb; 63(2):523-9. PubMed ID: 20954187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative transcriptome analysis reveals a potential role for CaMK4 in γδT17 cells from systemic lupus erythematosus patients with lupus nephritis.
    Du B; Fan X; Lei F; Zhang S; Li G; Xi X
    Int Immunopharmacol; 2020 Mar; 80():106139. PubMed ID: 31978801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
    Otomo K; Koga T; Mizui M; Yoshida N; Kriegel C; Bickerton S; Fahmy TM; Tsokos GC
    J Immunol; 2015 Dec; 195(12):5533-7. PubMed ID: 26561550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.
    Kono M; Yoshida N; Maeda K; Suárez-Fueyo A; Kyttaris VC; Tsokos GC
    Arthritis Rheumatol; 2019 Nov; 71(11):1869-1878. PubMed ID: 31233276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
    Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
    Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.
    Koga T; Hedrich CM; Mizui M; Yoshida N; Otomo K; Lieberman LA; Rauen T; Crispín JC; Tsokos GC
    J Clin Invest; 2014 May; 124(5):2234-45. PubMed ID: 24667640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of CaMK4 in immune responses.
    Koga T; Kawakami A
    Mod Rheumatol; 2018 Mar; 28(2):211-214. PubMed ID: 29252071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus.
    Koga T; Ichinose K; Mizui M; Crispín JC; Tsokos GC
    J Immunol; 2012 Oct; 189(7):3490-6. PubMed ID: 22942433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation.
    Kono M; Maeda K; Stocton-Gavanescu I; Pan W; Umeda M; Katsuyama E; Burbano C; Orite SYK; Vukelic M; Tsokos MG; Yoshida N; Tsokos GC
    JCI Insight; 2019 Jun; 4(12):. PubMed ID: 31217348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of calcium/calmodulin-dependent protein kinase IV in arthritis: dual effect on Th17 cell activation and osteoclastogenesis.
    Koga T; Umeda M; Yoshida N; Satyam A; Jha M; Scherlinger M; Bhargava R; Tsokos MG; Sato T; Furukawa K; Endo Y; Fukui S; Iwamoto N; Abiru N; Okita M; Ito M; Kawakami A; Tsokos GC
    Rheumatology (Oxford); 2023 Feb; 62(2):861-871. PubMed ID: 35781320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro silencing of RIP2 in naive CD4
    Song ZC; Liu ST; Xia XY; Hu JJ; Leng RX; Zhao W
    Clin Rheumatol; 2024 Nov; 43(11):3515-3523. PubMed ID: 39235498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CaMK4 promotes abortion-related Th17 cell imbalance by activating AKT/mTOR signaling pathway.
    Chang S; Yin T; He F; Ding J; Shang Y; Yang J
    Am J Reprod Immunol; 2020 Dec; 84(6):e13315. PubMed ID: 32738170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium/Calmodulin-Dependent Kinase IV Facilitates the Recruitment of Interleukin-17-Producing Cells to Target Organs Through the CCR6/CCL20 Axis in Th17 Cell-Driven Inflammatory Diseases.
    Koga T; Otomo K; Mizui M; Yoshida N; Umeda M; Ichinose K; Kawakami A; Tsokos GC
    Arthritis Rheumatol; 2016 Aug; 68(8):1981-8. PubMed ID: 26945541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p.
    Cheng T; Ding S; Liu S; Li X; Tang X; Sun L
    Front Immunol; 2021; 12():668760. PubMed ID: 34093566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the pathogenic significance of altered calcium-calmodulin signaling in T cells in autoimmune diseases.
    Koga T
    Clin Immunol; 2024 May; 262():110177. PubMed ID: 38460894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus Nephritis IgG Induction of Calcium/Calmodulin-Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function.
    Ichinose K; Ushigusa T; Nishino A; Nakashima Y; Suzuki T; Horai Y; Koga T; Kawashiri SY; Iwamoto N; Tamai M; Arima K; Nakamura H; Obata Y; Yamamoto K; Origuchi T; Nishino T; Kawakami A; Tsokos GC
    Arthritis Rheumatol; 2016 Apr; 68(4):944-52. PubMed ID: 26636664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice.
    Lin M; Huang L; Huang J; Yu J; Yang X; Yang J
    J Autoimmun; 2024 May; 145():103198. PubMed ID: 38428341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.